Shuimu BioSciences

company

About

Shuimu BioSciences provides one-stop solutions for cryo-EM-Powered drug discovery.

  • 51 - 100

Details

Last Funding Type
Angel
Last Funding Money Raised
¥15M
Industries
Biotechnology,Life Science
Founded date
Dec 7, 2017
Number Of Employee
51 - 100
Operating Status
Active

Shuimu harnesses the power of cryo-EM and Artificial Intelligence to help pharma and biotech companies discover and develop novel therapeutics faster and better, breaks new ground to develop precision medicines for the most challenging diseases on our planet.
With eight 300kv Cryo-EM’s in house, proprietory GraFuture technologies, AI driven data processing and modeling platforms, Shuimu is your best partner with one-stop solutions in structure based drug and therapeutic innovation, from sequence to structure.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
¥15M
Shuimu BioSciences has raised a total of ¥15M in funding over 2 rounds. Their latest funding was raised on Jan 1, 2020 from a Angel round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jan 1, 2020 Angel ¥15M 1 Gaorong Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Shuimu BioSciences is funded by 1 investors. Gaorong Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Gaorong Capital Yes Angel